Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Valproate semisodium (Primary)
- Indications Schizoaffective disorder; Schizophrenia; Toxoplasmosis
- Focus Therapeutic Use
- 24 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 24 Oct 2016 Planned End Date changed from 1 Mar 2015 to 1 Oct 2017.
- 22 Dec 2013 New trial record